Fifty eight large bowel adenocarcinomas and 20 adenomas were studied immunohistochemically, using fresh frozen tissue sections, with regard to lymphocyte subpopulations (CD3, CD4, CD8, CD19, and CD20) in the inflammatory infiltrate and to expression ofhuman leucocyte antigens (HLA-ABC, HLA-A2, and HLA-DR). The findings were related to differentiation and Dukes's stage of carcinoma. The inflammatory infiltrate was found to have a phenotype that remained constant irrespective of the intensity of the inflammation. CD4 and CD3 positive cells predominated with fewer CD8 positive cells and a scanty diffuse CDl9/20 positive cell population. CD19120 follicular aggregates were common at the advancing margin of the carcinomas. There was no significant association with Dukes's stage, differentiation or HLA status. HLA changes (ABC loss, A2 loss, and DR gain) were associated with differentiation, being more common and more extensive in poorly differentiated carcinomas. HLA-A2 loss was also associated with stage of progression of carcinoma. Inflammation associated with adenomas was found to have a similar phenotype to that associated with carcinomas. HLA changes in adenomas were uncommon, being seen in only one of our 20 cases.
Results vary depending upon the methods used and are difficult to interpret.8-"1 Others have shown an association between the type of lymphocytes in the infiltrate and the human leucocyte antigen (HLA) status of the carcinoma. 12 Theoretically, antigen presentation in the HLA system could govern lymphocyte activation and destruction of carcinoma cells, or conversely lead to evasion of immune surveillance and so advance the disease.
Many changes in HLA class I and II have been shown, generally showing a variable loss in HLA-ABC and a gain in HLA-DR. Only a gain in HLA-DR has been linked with survival irrespective of Dukes's stage,'3 although even this finding was at variance with the findings of others.
In an attempt to support some of these findings we have analysed 58 colorectal carcinomas using immunohistochemical staining methods. In addition we also studied 20 colonic adenomas. Monoclonal antibodies directed against a variety of lymphocyte subsets and HLA antigens were used on frozen tissue sections. At present, insufficient time has elapsed to assess the associations with survival.
Methods
Fifty eight specimens of colorectal carcinoma were received and dissected fresh. Macroscopic tumour was sectioned and pieces taken from proximal, central, and distal regions of tumour together with one piece of normal colon away from the carcinoma. Samples were snap frozen in isopentane, precooled in liquid nitrogen, and stored at -70°C until required. The main specimen was then fixed and processed to paraffin wax sections for histological diagnosis.
Twenty adenomas submitted were treated in a similar way.
Sections of each of the blocks were stained immunohistochemically using standard techniques with antibodies shown in After staining, sections were evaluated independently by two of the authors. The intensity of peritumoral inflammatory infiltrate was graded on a scale of 0-3 using the haematoxylin and eosin sections according to the criteria of Jass.4 A similar graded assessment was made for intratumoral and intraepithelial lymphocytic infiltrate.
Lymphocyte subsets were assessed, for each of the antibodies detailed, in a similar fashion and a note made of the pattern of the infiltra- tion and any follicular aggregates (Fig 1) . When agreement between the two assessors was good, a final score was reached by combining the results. When it was poor, the cases were reviewed using a double headed microscope and a score agreed after discussion.
HIA was assessed on a scale of 0-4 according to the percentage change in tumour staining (positive to negative for HLA-ABC loss and HLA-A2 loss, negative to positive for HLA-DR gain). The scoring was: O=no change, 1=less than 10%, 2=11-50%, 3=51-90%, 4=91-100%. Figure 2 shows an example. Spearman's rank correlation coefficient was used to assess significance of changes.
Routinely processed material was used to assess differentiation and stage of carcinoma. The differentiation and stage was assessed by one of the authors (PJ) and compared with the original pathology report checked by another of the authors (MGC). Adenomas were assessed separately for dysplasia using the frozen material. invasive carcinoma elsewhere in the colon apart from two patients with familial adenomatous polyposis and no carcinoma. The adenomas were all less than 25 mm in diameter and epithelial dysplasia was judged as mild in 10 cases and moderate in 10 cases. No severely dysplastic adenomas were present. The pattern of infiltration in the stroma of the adenomas was phenotypically similar to the infiltrate around carcinomas, except that the diffuse B cell population was more prominent. HLA changes in adenomas were infrequent, none lost HLA-ABC, one of 11 cases expressing HLA-A2 in normal epithelium showed loss and the same single case showed DR gain.
Results
In both carcinomas and adenomas there was no correlation between changes in HLA status and the inflammatory infiltrate either qualitative or quantitative. There was no observable difference in any of the parameters measured between tissue from different sites in the same tumour (proximal, central, or distal).
Discussion
The prognostic significance of staging carcinoma of colorectum is widely accepted. One of the earliest and simplest systems, namely that of Dukes, is accurate and reproducible but improvements are feasible. '5 16 The overall effect of tumour grade or differentiation on survival is debated.1 16 Other proposed systems for predicting prognosis include the degree of lymphocytic infiltrate and type of infiltrative margin of the tumour.7 Our study has shown that the degree of inflammation both at the advancing margin and in the intratumoral stroma of a carcinoma, tends to diminish as the stage of disease increases. While the results do not reach significance they are in accordance with the findings of others.5 17 No relation was shown between differentiation of carcinoma and the degree of inflammation in contrast with an association that has been shown by others.5 This may relate to the comparatively low number of well differentiated carcinomas in our study, being insufficient to show a statistical association.
Having considered that the degree of inflammation relates to progression of carcinoma, some authors have attempted to characterise the inflammatory infiltrate, but with conflicting results.8 17 Considering changes in HLA status we found no relation between HLA changes and the intensity of inflammatory infiltrate, again in contrast with an association that has been previously shown.'2 This study related T8 intraepithelial lymphocytes to HLA-DR gain but we were unable to score these reliably because of the low number of cells. This same study showed no difference in the much more intense stromal inflammatory infiltrate between HLA-DR positive and HLA-DR negative cases.
We have shown that loss of HLA-A2 staining in carcinomas is associated with stage of tumour progression and that changes in HLA-ABC are not common, occurring in only 13% of cases overall, with no significant stage association. These are findings that support the suggestions that single allelic changes are more common than suggested by broad spectrum HLA staining.'9-2' Gain in HLA-DR within carcinomas showed no association with stage.
In our series there was an association between HLA status and the degree of differentiation of carcinomas. suggested that strong HLA-DR staining points to a good prospect for survival even in more advanced stages of disease'3 and it will be interesting to follow up this subset of patients in our group.
In the adenomas we studied there was one case that showed both HLA-A2 loss and HLA-DR gain, whereas the other 19 cases did not change. It is interesting to note that a synchronous carcinoma in this one case showed similar changes in HLA status. It has been stated that adenomas often gain HLA-DR and lose class I antigens at least in familial polyposis syndromes25 26 where there may also be associated changes in inflammatory infiltrates. Our series included adenomas from two cases of familial polyposis and these did not show any change. However, it is difficult to draw conclusions from our two cases.
In summary, our findings show that the inflammatory infiltrate related to a carcinoma has a set pattern (phenotype) and that only the intensity varies, but the intensity of inflammation is only weakly related to the stage of carcinoma.
Changes in HLA status are linked to the degree of differentiation rather than stage of a carcinoma, with the exception of a single allelic determinant HLA-A2 that is also linked to stage.
No association was found between HLA and inflammation and it does not therefore seem possible to support ideas of HIA changes governing the inflammatory response to carcinomas in vivo despite the previously seen links between T cell subset activation and antigens of HLA class I and II. It would seem from our results that immune surveillance relates to overall numbers of lymphocytes of a reproducible phenotype that is not governed by HLA changes, but failure of which is associated with, or even leads to, progression of carcinoma. We have insufficient evidence to show progressive changes in an adenomacarcinoma sequence.
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